This Article
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wittes, R. C.
Right arrow Articles by Saginur, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wittes, R. C.
Right arrow Articles by Saginur, R.

Canadian Medical Association Journal, Vol 152, Issue 4 515-517, Copyright © 1995 by Canadian Medical Association

JOURNAL ARTICLE

Adverse reaction to mefloquine associated with ethanol ingestion

R. C. Wittes and R. Saginur
Division of Infectious Disease, Ottawa Civic Hospital, Ont.

A 40-year-old man with no history of neuropsychiatric illness was taking one 250-mg tablet of mefloquine (MFQ) weekly for malaria prophylaxis while in Tanzania. He experienced no adverse reaction in association with his first two doses. Concurrently with both his third and his fourth dose he consumed about half a litre of whisky. On both occasions he experienced hallucinations, paranoid delusions and suicidal ideation. Thereafter he continued taking the MFQ, abstained completely from ethanol ingestion and had no recurrence of psychiatric symptoms. It is hypothesized that the combination of MFQ and ethanol caused the two episodes of severe psychiatric disturbance.


This article has been cited by other articles:


Home page
 JAMAHome page
L. H. Chen, M. E. Wilson, and P. Schlagenhauf
Controversies and Misconceptions in Malaria Chemoprophylaxis for Travelers
JAMA, May 23, 2007; 297(20): 2251 - 2263.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
E. Wooltorton
Mefloquine: contraindicated in patients with mood, psychotic or seizure disorders
Can. Med. Assoc. J., November 12, 2002; 167(10): 1147 - 1147.
[Full Text] [PDF]